{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:30:29Z","timestamp":1793961029978,"version":"4.8.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.eprac.2026.05.032","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:22:07Z","timestamp":1780503727000},"page":"1617-1622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Increased Risk of Venous Thromboembolism in Patients With Thyroid Eye Disease Compared to Graves\u2019 Disease Without Orbitopathy"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5638-8962","authenticated-orcid":false,"given":"Aaron T.","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Katowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eprac.2026.05.032_bib1","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eprac.2026.05.032_bib2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2169\/internalmedicine.53.1518","article-title":"Graves' ophthalmopathy: epidemiology and natural history","volume":"53","author":"Hiromatsu","year":"2014","journal-title":"Intern Med"},{"key":"10.1016\/j.eprac.2026.05.032_bib3","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves' ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eprac.2026.05.032_bib4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/WNO.0000000000000132","article-title":"The pathophysiology of thyroid eye disease","volume":"34","author":"Shan","year":"2014","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.eprac.2026.05.032_bib5","first-page":"171","article-title":"Autoimmune diseases and venous thromboembolism: a review of the literature","volume":"2","author":"Z\u00f6ller","year":"2012","journal-title":"Am J Cardiovasc Dis"},{"key":"10.1016\/j.eprac.2026.05.032_bib6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(11)61306-8","article-title":"Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden","volume":"379","author":"Z\u00f6ller","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.eprac.2026.05.032_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1741-7015-9-1","article-title":"Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study","volume":"9","author":"Ramagopalan","year":"2011","journal-title":"BMC Med"},{"key":"10.1016\/j.eprac.2026.05.032_bib8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.md.0000091181.93122.55","article-title":"Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients","volume":"82","author":"Cervera","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.eprac.2026.05.032_bib9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10067-014-2492-7","article-title":"Risk of venous thromboembolism in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"33","author":"Ungprasert","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.eprac.2026.05.032_bib10","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(09)61963-2","article-title":"Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study","volume":"375","author":"Grainge","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.eprac.2026.05.032_bib11","article-title":"Recurrence rate of venous thromboembolic events in granulomatosis with polyangiitis","volume":"6","author":"Nevares","year":"2022","journal-title":"Rheumatol Adv Pract"},{"key":"10.1016\/j.eprac.2026.05.032_bib12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2141.2005.05753.x","article-title":"The interactions between inflammation and coagulation","volume":"131","author":"Esmon","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.eprac.2026.05.032_bib13","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nri2171","article-title":"Evolving functions of endothelial cells in inflammation","volume":"7","author":"Pober","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.eprac.2026.05.032_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/jamiaopen\/ooad035","article-title":"A global federated real-world data and analytics platform for research","volume":"6","author":"Palchuk","year":"2023","journal-title":"JAMIA Open"},{"key":"10.1016\/j.eprac.2026.05.032_bib15","doi-asserted-by":"crossref","first-page":"I9","DOI":"10.1161\/01.CIR.0000078469.07362.E6","article-title":"Risk factors for venous thromboembolism","volume":"107","author":"Anderson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.eprac.2026.05.032_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11239-015-1311-6","article-title":"The epidemiology of venous thromboembolism","volume":"41","author":"Heit","year":"2016","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.eprac.2026.05.032_bib17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1530\/eje.0.1430197","article-title":"Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking","volume":"143","author":"Salvi","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eprac.2026.05.032_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29113-2","article-title":"Differential profiling of lacrimal cytokines in patients suffering from thyroid-associated orbitopathy","volume":"8","author":"Kishazi","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.eprac.2026.05.032_bib19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/jc.2018-01493","article-title":"Potential roles of CD34+ fibrocytes masquerading as orbital fibroblasts in thyroid-associated ophthalmopathy","volume":"104","author":"Smith","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2026.05.032_bib20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/thy.1998.8.415","article-title":"Cytokines in thyroid eye disease: potential for anticytokine therapy","volume":"8","author":"Bahn","year":"1998","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2026.05.032_bib21","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41433-018-0279-9","article-title":"The involvement of T cell pathogenesis in thyroid-associated ophthalmopathy","volume":"33","author":"Huang","year":"2019","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.eprac.2026.05.032_bib22","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1167\/iovs.18-24008","article-title":"Interaction between CCR6+ Th17 cells and CD34+ fibrocytes promotes inflammation: implications in graves' orbitopathy in Chinese population","volume":"59","author":"Fang","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.eprac.2026.05.032_bib23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/jamaophthalmol.2018.0806","article-title":"Association of T and B cells infiltrating orbital tissues with clinical features of graves orbitopathy","volume":"136","author":"Rotondo","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.eprac.2026.05.032_bib24","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1182\/blood.V89.2.541","article-title":"Monocytes upregulate endothelial cell expression of tissue factor: a role for cell-cell contact and cross-talk","volume":"89","author":"Napoleone","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.eprac.2026.05.032_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2141.2001.03061.x","article-title":"Interleukin 6 and haemostasis","volume":"115","author":"Kerr","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.eprac.2026.05.032_bib26","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","article-title":"Endothelial cell dysfunction and the pathobiology of atherosclerosis","volume":"118","author":"Gimbrone","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.eprac.2026.05.032_bib27","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Dav\u00ec","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eprac.2026.05.032_bib28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.eprac.2026.05.032_bib29","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1146\/annurev-physiol-012110-142305","article-title":"Venous valvular stasis-associated hypoxia and thrombosis: what is the link?","volume":"73","author":"Bovill","year":"2011","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.eprac.2026.05.032_bib30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/annrheumdis-2020-218419","article-title":"Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden","volume":"80","author":"Molander","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.eprac.2026.05.032_bib31","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jamainternmed.2013.122","article-title":"Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study","volume":"173","author":"Johannesdottir","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.eprac.2026.05.032_bib32","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/bjh.17388","article-title":"Glucocorticoid use and risk of first and recurrent venous thromboembolism: self-controlled case-series and cohort study","volume":"193","author":"Orsi","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.eprac.2026.05.032_bib33","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.wneu.2016.01.033","article-title":"Association of steroid use with deep venous thrombosis and pulmonary embolism in neurosurgical patients: a national database analysis","volume":"89","author":"Lieber","year":"2016","journal-title":"World Neurosurg"},{"key":"10.1016\/j.eprac.2026.05.032_bib34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ophtha.2009.07.017","article-title":"The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia","volume":"117","author":"Rogers","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.eprac.2026.05.032_bib35","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/eye.2017.260","article-title":"Orbital decompression for thyroid eye disease: methods, outcomes, and complications","volume":"32","author":"Jefferis","year":"2018","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.eprac.2026.05.032_bib36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.116.024507","article-title":"Association of traditional cardiovascular risk factors with venous thromboembolism: an individual participant data meta-analysis of prospective studies","volume":"135","author":"Mahmoodi","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.eprac.2026.05.032_bib37","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000035329","article-title":"Association between diabetes and venous thromboembolism: a systematic review and meta-analysis","volume":"102","author":"Ding","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.eprac.2026.05.032_bib38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.diabres.2015.10.019","article-title":"Diabetes mellitus and venous thromboembolism: a systematic review and meta-analysis","volume":"111","author":"Bell","year":"2016","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26010244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26010244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:10:15Z","timestamp":1793959815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X26010244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1530891X26010244"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2026.05.032","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased Risk of Venous Thromboembolism in Patients With Thyroid Eye Disease Compared to Graves\u2019 Disease Without Orbitopathy","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2026.05.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AACE. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}